Market dynamics for generics must change amid ANDA pilot debut
The US Food and Drug Administration’s (FDA’s) pilot scheme to expedite the review of US-made generic medicines is welcomed but…
News
Adcytherix gains $122m to propel ADC development
EMD Serono partners US government to widen IVF access
AstraZeneca doubles Lokelma output with $445m Texas plant expansion
Novo Nordisk snaps up Omeros’ rare disease asset for up to $2.1bn
Bavarian Nordic’s shareholders and board in standoff amid takeover offer
Tubulis closes $361m in Series C to advance cancer treatment
Oceanpine Capital to acquire 80% equity stake in Beijing Jacoray
